Vaxart, Inc. (VXRT): EPS (Basic)
$0.07
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0.07 | n/m | 2026-03-13, From 2025-01-01 |
| 2024-12-31 | -$0.33 | n/m | 2026-03-13, From 2024-01-01 |
| 2023-12-31 | -$0.57 | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$0.84 | n/m | 2024-03-14, From 2022-01-01 |
| 2021-12-31 | -$0.58 | n/a | 2023-03-15, From 2021-01-01 |
| No annual figure between 2017-06-30 and 2021-12-31. | |||
| 2017-06-30 | -$0.76 | n/m | 2017-09-01, From 2016-07-01 |
| 2016-06-30 | -$0.66 | n/m | 2017-09-01, From 2015-07-01 |
| 2015-06-30 | -$0.54 | n/m | 2016-09-13, From 2014-07-01 |
| 2014-06-30 | -$0.35 | n/m | 2016-09-13, From 2013-07-01 |
| 2013-06-30 | -$0.32 | n/m | 2015-09-11, From 2012-07-01 |
| 2012-06-30 | -$0.85 | n/m | 2013-09-27, From 2011-07-01 |
| 2011-06-30 | -$1.12 | n/a | 2013-09-27, From 2010-07-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Vaxart, Inc. (VXRT) | 2025-12-31 | $0.07 | n/m |
| Iovance Biotherapeutics, Inc. (IOVA) | 2025-12-31 | -$1.09 | n/m |
| Vericel Corp (VCEL) | 2025-12-31 | $0.33 | +57.1% |
| Adaptive Biotechnologies Corp (ADPT) | 2025-12-31 | -$0.39 | n/m |
| Adaptimmune Therapeutics PLC (ADAPY) | 2024-12-31 | -$0.05 | n/m |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | -$3.76 | n/m |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | -$5.64 | n/m |
| Twist Bioscience Corp (TWST) | 2025-09-30 | -$1.30 | n/m |
| Krystal Biotech, Inc. (KRYS) | 2025-12-31 | $7.08 | +126.9% |
Compare VXRT, IOVA, VCEL, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗